Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis

Medical Journal of Australia

Volumn 182, Issue 9, 2005, Pages 482-483

  Skowronski, Emma ^a   Fitzgerald, Dominic A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CEFOTAXIME; CORTICOSTEROID; FLUCLOXACILLIN; IMMUNOGLOBULIN E; ITRACONAZOLE; OXYGEN; PREDNISONE; ROXITHROMYCIN; SALBUTAMOL;

ARTERIAL GAS; ARTICLE; ASPERGILLUS FUMIGATUS; ASSISTED VENTILATION; BLOOD CELL COUNT; BODY WEIGHT DISORDER; BRONCHOPULMONARY ASPERGILLOMA; CASE REPORT; CUSHINGOID SYNDROME; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; INTENSIVE CARE; LEUKOCYTOSIS; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION; MALE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY FAILURE; SCHOOL CHILD; SKIN TEST; SPIROMETRY; SUBCUTANEOUS EMPHYSEMA; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; WEIGHT GAIN;

EID: 18744389791     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06792.x     Document Type: Article

References (14)

1. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiologic study. Eur Respir J 2000; 16: 464-471.
2. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994; 105: 32-36.
3. Proceedings of the Cystic Fibrosis Foundation ABPA consensus conference. Bethesda, Md: 2001 Jun 12-13. Bethesda, Md: North American Cystic Fibrosis Foundation, 2002.
4. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685-692.
5. Varkey B. Allergic bronchopulmonary aspergillosis: clinical perspectives. Immunol Allergy Clin North Am 1998; 18: 479-501.
6. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756-762.
7. Vaughan LM. Allergic bronchopulmonary aspergillosis. Clin Pharm 1993; 12: 24-33.
8. Fitzgerald DA, Cooper DM, Paul M, et al. Burkholderia cepacia in cystic fibrosis: novel Australian cluster strain without accelerated respiratory deterioration. J Paediatr Child Health 2001; 37: 130-136.
9. Lee TM, Greenberger PA, Patterson R, et al. Stage V [fibrotic] allergic bronchopulmonary aspergillosis. A review of 17 cases followed from diagnosis. Arch Intern Med 1987; 147: 319-323.
10. Knutsen AP. Bellone C, Kauffman H. Immunopathogenesis of allergic bronchopulmonary aspergillosis. J Cystic Fibrosis 2002; 2: 76-89.
11. Klein NC, Cunha BA. New antifungal drugs for pulmonary mycoses. Chest 1996; 110: 525-532.
12. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999; 115: 364-370.
13. Wark PAB, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952-957.
14. Skov M, Main KM, Sillesen IB, et al. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 2002; 20: 127-133.